Drug Profile
Amoxicillin/clarithromycin pulsatile - Advancis
Alternative Names: Amoxicillin/clarithromycin PULSYS™; Pulsatile amoxicillin/clarithromycin; PULSYS™ amoxicillin/clarithromycinLatest Information Update: 15 May 2007
Price :
$50
*
At a glance
- Originator Advancis Pharmaceutical
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 15 May 2007 Discontinued - Phase-I/II for Bacterial infections in USA (PO)
- 01 Apr 2004 Phase-I/II clinical trials in Bacterial infections in USA (PO)